Vertex Pharmaceuticals Incorporated

06/02/2022 | Press release | Distributed by Public on 06/02/2022 08:12

Vertex and CRISPR Therapeutics Announce Acceptance of Late-Breaking Abstract for CTX001™ at the 2022 Annual European Hematology Association (EHA) Congress